Patent · US Active

Alpha-hemolysin variants

US10227645B2 · kind B2 · utility

2Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2016
Grant dateMar 12, 2019
Priority date—
Expiry dateOct 20, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/1241
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.